These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 25689547)
1. The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction. Casassus F; Corre J; Leroux L; Chevalereau P; Fresselinat A; Seguy B; Calderon J; Coste P; Ouattara A; Roques X; Barandon L J Interv Cardiol; 2015 Feb; 28(1):41-50. PubMed ID: 25689547 [TBL] [Abstract][Full Text] [Related]
2. The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock. Pieri M; Sorrentino T; Oppizzi M; Melisurgo G; Lembo R; Colombo A; Zangrillo A; Pappalardo F J Interv Cardiol; 2018 Dec; 31(6):717-724. PubMed ID: 30460719 [TBL] [Abstract][Full Text] [Related]
3. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Schrage B; Ibrahim K; Loehn T; Werner N; Sinning JM; Pappalardo F; Pieri M; Skurk C; Lauten A; Landmesser U; Westenfeld R; Horn P; Pauschinger M; Eckner D; Twerenbold R; Nordbeck P; Salinger T; Abel P; Empen K; Busch MC; Felix SB; Sieweke JT; Møller JE; Pareek N; Hill J; MacCarthy P; Bergmann MW; Henriques JPS; Möbius-Winkler S; Schulze PC; Ouarrak T; Zeymer U; Schneider S; Blankenberg S; Thiele H; Schäfer A; Westermann D Circulation; 2019 Mar; 139(10):1249-1258. PubMed ID: 30586755 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up. Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627 [TBL] [Abstract][Full Text] [Related]
5. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative. Basir MB; Schreiber T; Dixon S; Alaswad K; Patel K; Almany S; Khandelwal A; Hanson I; George A; Ashbrook M; Blank N; Abdelsalam M; Sareen N; Timmis SBH; O'Neill Md WW Catheter Cardiovasc Interv; 2018 Feb; 91(3):454-461. PubMed ID: 29266676 [TBL] [Abstract][Full Text] [Related]
6. Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study. Bochaton T; Huot L; Elbaz M; Delmas C; Aissaoui N; Farhat F; Mewton N; Bonnefoy E; Arch Cardiovasc Dis; 2020 Apr; 113(4):237-243. PubMed ID: 31740272 [TBL] [Abstract][Full Text] [Related]
7. Early Impella Support in Postcardiac Arrest Cardiogenic Shock Complicating Acute Myocardial Infarction Improves Short- and Long-Term Survival. Chatzis G; Markus B; Luesebrink U; Ahrens H; Divchev D; Syntila S; Scheele N; Al Eryani H; Tousoulis D; Schieffer B; Karatolios K Crit Care Med; 2021 Jun; 49(6):943-955. PubMed ID: 33729726 [TBL] [Abstract][Full Text] [Related]
8. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047 [TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597 [TBL] [Abstract][Full Text] [Related]
10. Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival. Meraj PM; Doshi R; Schreiber T; Maini B; O'Neill WW J Interv Cardiol; 2017 Jun; 30(3):256-263. PubMed ID: 28419573 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. Ouweneel DM; Eriksen E; Sjauw KD; van Dongen IM; Hirsch A; Packer EJ; Vis MM; Wykrzykowska JJ; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; de Mol BA; Tijssen JG; Henriques JP J Am Coll Cardiol; 2017 Jan; 69(3):278-287. PubMed ID: 27810347 [TBL] [Abstract][Full Text] [Related]
13. A Comparison of In-Hospital Outcomes Between the Use of Impella and IABP in Acute Myocardial Infarction Cardiogenic Shock Undergoing Percutaneous Coronary Intervention. Jin C; Yandrapalli S; Yang Y; Liu B; Aronow WS; Naidu SS J Invasive Cardiol; 2022 Feb; 34(2):E98-E103. PubMed ID: 35100554 [TBL] [Abstract][Full Text] [Related]
14. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock. Helgestad OKL; Josiassen J; Hassager C; Jensen LO; Holmvang L; Udesen NLJ; Schmidt H; Berg Ravn H; Moller JE Open Heart; 2020; 7(1):e001214. PubMed ID: 32201591 [TBL] [Abstract][Full Text] [Related]
15. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Shah M; Patnaik S; Patel B; Ram P; Garg L; Agarwal M; Agrawal S; Arora S; Patel N; Wald J; Jorde UP Clin Res Cardiol; 2018 Apr; 107(4):287-303. PubMed ID: 29134345 [TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcomes in patients with cardiogenic shock complicating acute myocardial infarction: early vs recent experience with impella. Singh H; Mehta RH; O'Neill W; Kapur NK; Lalonde T; Ohman M; Ghiu I; Chen-Hsing Y; Dutcheshen K; Schreiber T; Rosman H; Kaki A Am Heart J; 2021 Aug; 238():66-74. PubMed ID: 33848505 [TBL] [Abstract][Full Text] [Related]
17. MI2AMI-CS: A meta-analysis comparing Impella and IABP outcomes in Acute Myocardial Infarction-related Cardiogenic Shock. De Ferrari T; Pistelli L; Franzino M; Molinero AE; De Santis GA; Di Carlo A; Vetta G; Parlavecchio A; Fimiani L; Picci A; Certo G; Parisi F; Venuti G Int J Cardiol; 2024 Nov; 414():132411. PubMed ID: 39094635 [TBL] [Abstract][Full Text] [Related]
18. Prospective Comparison of a Percutaneous Ventricular Assist Device and Venoarterial Extracorporeal Membrane Oxygenation for Patients With Cardiogenic Shock Following Acute Myocardial Infarction. Garan AR; Takeda K; Salna M; Vandenberge J; Doshi D; Karmpaliotis D; Kirtane AJ; Takayama H; Kurlansky P J Am Heart Assoc; 2019 May; 8(9):e012171. PubMed ID: 31041870 [TBL] [Abstract][Full Text] [Related]
19. Combined hemodynamic support with the Impella 2.5 device and intra-aortic balloon pump for management of refractory cardiogenic shock. Pavlidis AN; Redwood SR; Clapp BR J Invasive Cardiol; 2014 May; 26(5):E50-1. PubMed ID: 24791724 [TBL] [Abstract][Full Text] [Related]
20. A goal-oriented hemodynamic approach to acute myocardial infarction complicated by cardiogenic shock-A single center experience. Siebert V; Goldstein J; Khan R; Lopez J; Darki A; Lewis B; Steen L; Doukas D Catheter Cardiovasc Interv; 2023 Oct; 102(4):569-576. PubMed ID: 37548088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]